• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - MINNETONKA AMS UROLUME ENDOPROSTHESIS; STENT, URETHRAL, BULBOUS, PERMANENT OR SEMI-PERMANENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - MINNETONKA AMS UROLUME ENDOPROSTHESIS; STENT, URETHRAL, BULBOUS, PERMANENT OR SEMI-PERMANENT Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Incontinence (1928); Burning Sensation (2146); Stenosis (2263); Dysuria (2684)
Event Type  Injury  
Event Description
It was reported by the patient that 13 years after the implantation of a urolume device, the patient experienced "lack of urination and constriction started"."i was born in (b)(6).At 6 years of age, i experienced a fall-related urethral stenosis.Urethra crushing has arrived.I once had open surgery.In 1992, urolume was installed in (b)(6) hospital."the operation went smoothly.Urolume was said to be a new stent.Presence of preoperative stenosis and voiding difficulties were promised to end.I had been discharged home at the end of the hospital, and when i went to check, it was stated that everybody passed perfectly.I do not remember having complications after surgery.Thirteen years after the application of urolume, when the lack of urination and constriction started, the urethra was first opened with the operation called tur to open the urinary tract.The urethra was completely closed after that.A second stent, which was said to be temporary as helpless but unknown to the name of the product, was inserted into the urolume nin.After this procedure, the urinary tract was reopened.For me, however, a troubled process has started for about 10 years.Often, problems such as urinary tract obstruction (most of the sperm are obstructing the urinary tract), excessive burning in the stent area, incontinence are increasing exponentially.I expect information and assistance from you first.I would like you to direct me to a specialist hospital or a urologist who is in charge of the issue for my remedies and problems".This information was provided to the patient liaison for response to the patient.No further patient complications were reported in relation with this event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
AMS UROLUME ENDOPROSTHESIS
Type of Device
STENT, URETHRAL, BULBOUS, PERMANENT OR SEMI-PERMANENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - MINNETONKA
10700 bren road w
minnetonka MN 55343
Manufacturer (Section G)
BOSTON SCIENTIFIC - MINNETONKA
10700 bren road w
minnetonka MN 55343
Manufacturer Contact
sharon zurn
10700 bren road w
minnetonka, MN 55343
9529306000
MDR Report Key6933729
MDR Text Key89125416
Report Number2183959-2017-00094
Device Sequence Number1
Product Code MES
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P920023
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type consumer
Reporter Occupation Other
Type of Report Initial
Report Date 10/03/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/10/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Was Device Available for Evaluation? No
Date Manufacturer Received10/03/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention; Disability;
-
-